ANI Pharmaceuticals Inc (ANIP) valuation · P/E 16, rev $883.4M
ANI Pharmaceuticals Inc (ANIP) P/E 16, rev $883.4M.
| Metric | Value |
|---|---|
| P/E | 16 |
| Market cap | $1.41B |
| Revenue | $883.4M |
| P/S | 1.6 |
ANIP valuation FAQ
What is ANIP's P/E ratio?
ANI Pharmaceuticals Inc (ANIP) trailing P/E is 16 on the latest cached fundamentals snapshot.
What is ANIP's market cap?
ANI Pharmaceuticals Inc (ANIP) market cap is $1.41B on the latest cached fundamentals snapshot.
What is ANIP's latest revenue?
Latest cached ANI Pharmaceuticals Inc (ANIP) revenue was $883.4M. Statements: https://lician.com/financials/anip
What is ANIP's price-to-sales ratio?
ANI Pharmaceuticals Inc (ANIP) price-to-sales (P/S) is 1.6, cached market cap $1.41B divided by revenue $883.4M.
How many ANIP valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for ANI Pharmaceuticals Inc (ANIP): P/E, Market cap, Revenue, and P/S.
Where is ANIP valuation listed?
Cached valuation multiples for ANI Pharmaceuticals Inc (ANIP) are listed at https://lician.com/valuation/anip.
Not investment advice. Cached rows, not a live tape.